The global leucovorin calcium market is anticipated to grow at a significant CAGR during the forecast period. The major factor that is expected to fuel the market includes the rise in the prevalence of cancer, which increases the need for leucovorin calcium, as it is an effective drug used during chemotherapy. Moreover, the rise in the prevalence of cancer in most of the developed and developing countries is another factor that is anticipated to boost the growth of the market during the forecast period. In 2020, around 19.3 million new cancer cases were recorded globally, which is projected to drive the demand for cancer treatment, which in turn is anticipated to increase the need for leucovorin calcium globally.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/leucovorin-calcium-market
Leucovorin calcium is an active metabolite of folic acid. Leucovorin calcium aids in providing a counteracting effect on the toxic medications, thereby protecting the patient while enabling the antitumor activity of the folate antagonist. Folinic acid, also known as leucovorin, is a medication used to decrease the toxic effects of methotrexate and pyrimethamine. It is also used in combination with 5-fluorouracil to treat colorectal cancer and pancreatic cancer may be used to treat folate deficiency that results in anemia, and methanol poisoning. Moreover, Leucovorin calcium also elevates the effect of fluorouracil as well as its derivatives by stabilizing the binding of the drug metabolites to a target enzyme. This aids in prolonging the drug activity. Leucovorin calcium can potentially enhance the effect of chemotherapy drugs and works as a chemo-protectant.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Teva Pharmaceutical Industries Ltd., Mylan N.V., and Hikma Pharmaceuticals plc, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Leucovorin Calcium Market Report by Segment
By Type
- Tablets
- Injection
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
A full report of Leucovorin Calcium Market is available at: https://www.omrglobal.com/industry-reports/leucovorin-calcium-market
Leucovorin Calcium Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Hikma Pharmaceuticals plc
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
